The center, located at 7845 Youree Drive in the WK Portico Center, offers among its services Tomosynthesis 3D Mammography, revolutionary technology that allows doctors to examine breast tissue one layer at a time with no additional compression and only a few seconds longer than a traditional mammogram. The Breast Health Center is the only facility in the region that offers core and stereotactic biopsies using this advanced technology.
Earlier in 2016 Willis-Knighton Health System purchased two Elekta Versa HD linear accelerators as part of the Willis-Knighton Cancer Center’s continuing technology upgrades. The first of the accelerators has been installed, and patients are currently being treated using this advanced linear accelerator technology.
Willis-Knighton Cancer Center will recognize cancer survivors on National Cancer Survivors Day Sunday, June 5, from 1 to 3 p.m. at the center, 2600 Kings Highway in Shreveport.
Willis-Knighton Health System recognized 62 high school graduates as part of its Give Back program.
Each year WK Sports Medicine offers free physical exams for high school athletes and eighth-grade student athletes entering high school in the fall. These exams were provided by 20 doctors from Willis-Knighton Health System and LSU Health Shreveport as well as 15 physical therapists, 10 athletic trainers and students from the Physical Therapy Assistant program at Bossier Parish Community College.
Christopher Shelby, MD, of WK Eye Institute has successfully performed the area’s first surgery to implant a miniature telescope in the eye of a patient with end-stage macular degeneration.
Willis-Knighton has received Full Chest Pain Center with Primary PCI Accreditation from the Society of Cardiovascular Patient Care (SCPC). Willis-Knighton is the only local facility that has achieved this designation.
Willis-Knighton Cancer Center is now offering Optune, a medical device that, when used in conjunction with partial-brain radiotherapy and chemotherapy, has been shown to extend overall survival and progression-free survival of newly diagnosed patients with glioblastoma multiforme (GBM). Optune is a portable, noninvasive device that delivers low-intensity, alternating electric fields (referred to as Tumor Treating Fields) that inhibit cancer cell replication and cause cancer cells to die.
Willis-Knighton was pleased to learn that the Caddo Parish School Board has accepted its bid for the Hamilton Terrace school property.
In January Willis-Knighton Cancer Center joins leading cancer centers in the United States in a new research initiative evaluating two types of radiation therapy approved by the U.S. Food & Drug Administration for the treatment of breast cancer.